Search / Trial NCT06613282

A Randomized, Single-blind Trial of LI-TMS and AVS for Stoke Recovery in Healthy Participants (Phase 1).

Launched by SIBERIAN SCIENTIFIC RESEARCH AND TEST CENTER FOR BIOMEDICAL ENGINEERING · Sep 23, 2024

Trial Information

Current as of October 03, 2024

Enrolling by invitation

Keywords

Low Intensity Transcranial Magnetic Stimulation Audio Visual Stimulation Avs Recovery After Stroke Stroke Rehabilitation Li Tms

Description

Stroke is a leading cause of disability worldwide, significantly impacting individuals; quality of life and their ability to perform daily activities. Rehabilitation is critical for stroke survivors as it aims to restore function, improve mobility, and enhance overall well-being. Auditory-visual stimulation (AVS) is a stroke rehabilitation technique that combines auditory and visual stimuli to promote cognitive and motor recovery. This approach is based on the principles of neuroplasticity, which suggest that engaging multiple senses through receptor systems can promote brain plasticity an...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants must be in good general health, as verified by reviewing their medical history and physical examination. They must not have any serious illnesses that could be a barrier to the research.
  • Exclusion Criteria:
  • 1. somatic and neurological diseases in the exacerbation stage;
  • 2. presence of epileptic seizures on the EEG;
  • 3. cognitive disorders;
  • 4. presence of visual and hearing pathologies that prevent the sessions;
  • 5. women during pregnancy.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Novosibirsk, Novosibirsk Region, Russian Federation

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0